ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1480

LncRNA XIST Alters the Balance of Peripheral Blood Immune Cells in Systemic Lupus Erythematosus by Regulating the miR-17-92/OFLM4 and CEACAM8 Axis

Qi Cheng, Mo Chen, xin Chen, peiyu zhang, huaxiang wu and yan du, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China (People's Republic)

Meeting: ACR Convergence 2021

Keywords: Bioinformatics, Epigenetics, Natural Killer Cells, Systemic lupus erythematosus (SLE), T-Lymphocyte

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 9, 2021

Title: SLE – Etiology & Pathogenesis Poster (1480–1506)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: X-inactive-specific transcript (XIST) has been shown to silence linked genes on the X chromosome that may be related to the pathogenesis of systemic lupus erythematosus (SLE) in female patients. However, the function of XIST in SLE at other levels remains unclear. The present study aimed to clarify the correlations between XIST expression and SLE clinical features and the contribution of XIST to SLE pathogenesis at the transcriptome level.

Methods: Expression of XIST in 79 SLE patients and 23 healthy controls was detected by quantitative-polymerase chain reaction. Bioinformatics methods were used to explore the function and regulatory mechanism of XIST.

Results: Expression of XIST was significantly upregulated in SLE patients compared with healthy controls (Figure 1A, p = 0.0043), and had a high diagnostic value for SLE (Figure 1B, AUC = 0.762, 95% CI: 0.658 to 0.867, p = 0.000136). Compared with male patients and older patients, XIST was significantly upregulated in female patients (Figure 1C, p = 0.0162) and younger patients (Figure 1D, p = 0.0429). Moreover, XIST was highly expressed in patients with arthralgia (Figure 1E, p = 0.0222). Importantly, SLE patients with high expression of XIST tended to have elevated levels of total T cells and CD8+ T cells, but reduced levels of Treg cells and NK cells. Bioinformatics analyses suggested that XIST may regulate the expression of OLFM4 and CEACAM8 by acting as a spongy body for miR-20a, miR-92a, miR-106a, and miR-449a (Figure 2). Furthermore, OLFM4 and CEACAM8 are significantly upregulated in SLE patients and had significant positive correlations with expression of XIST.

Conclusion: We propose that XIST may alter the balance of peripheral blood immune cells in SLE by acting as a spongy body for the miR-17-92 cluster and promoting the expression of OLFM4 and CEACAM8, resulting in immune dysregulation and tissue damage in SLE.

Figure 1 expression of lncRNA XIST and its diagnostic value for SLE. A. Expression of XIST in SLE patients and healthy controls. B. ROC curves of XIST in the two groups. C and D. XIST is significantly upregulated in female (C) and young (D) patients. E. XIST is highly expressed in patients with arthralgia.

Figure 2 Function and regulatory mechanism of XIST at transcriptome level. A.The ceRNA network was composed of 1 lncRNA, 8 miRNAs, 115 mRNAs, and 150 edges. Each edge represents one interaction between two transcripts. Red diamond, lncRNA; green V, miRNA; sky-blue circle, mRNA. B. Subnetwork of hub transcripts constructed by Cytoscape and its plug-in Cytohubba.


Disclosures: Q. Cheng, None; M. Chen, None; x. Chen, None; p. zhang, None; h. wu, None; y. du, None.

To cite this abstract in AMA style:

Cheng Q, Chen M, Chen x, zhang p, wu h, du y. LncRNA XIST Alters the Balance of Peripheral Blood Immune Cells in Systemic Lupus Erythematosus by Regulating the miR-17-92/OFLM4 and CEACAM8 Axis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/lncrna-xist-alters-the-balance-of-peripheral-blood-immune-cells-in-systemic-lupus-erythematosus-by-regulating-the-mir-17-92-oflm4-and-ceacam8-axis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lncrna-xist-alters-the-balance-of-peripheral-blood-immune-cells-in-systemic-lupus-erythematosus-by-regulating-the-mir-17-92-oflm4-and-ceacam8-axis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology